1. Comprehensive Management of Disseminated Colorectal Cancer

   • Paul H. Sugarbaker

   Gastrointestinal Oncology 19 October 2008 Pages: 3327 - 3330

   

2. The Intraductal Approach to Breast Cancer

   • William C. Dooley

   Breast Oncology 28 May 2008 Pages: 3331 - 3332

3. Surveys, Quality Cancer Care, and Evidence-Based Medicine: Embracing Care Delivery Drivers

   • Lawrence D. Wagman

   Healthcare Policy and Outcomes Open access 27 September 2008 Pages: 3333 - 3334

4. Predicting Life Expectancy and Symptom Relief Following Surgery for Advanced Malignancy

   • David D. Smith
   • Laurence E. McCahill

   Healthcare Policy and Outcomes 30 September 2008 Pages: 3335 - 3341

   

5. Implications of a Postoperative Rehabilitation Program on Quality of Life in Women with Primary Breast Cancer Treated with Sentinel Lymph Node Biopsy or Complete Axillary Lymph Node Dissection

   • Marcela Ponzio Pinto e Silva
   • Luis Otávio Sarian
   • Sophie Derchain

   Breast Oncology 17 October 2008 Pages: 3342 - 3349

6. The Role of Mammary Ductoscopy in Breast Cancer: a Review of the Literature

   • Edna Kapenhas-Valdes
   • Sheldon M. Feldman
   • Susan K. Boolbol

   Breast Oncology 08 October 2008 Pages: 3350 - 3360

   

7. Factors Affecting Axillary Lymph Node Retrieval and Assessment in Breast Cancer Patients

   • T. Cil
   • J. Hauspy
   • C. M. B. Holloway

   Breast Oncology 01 October 2008 Pages: 3361 - 3368

   

8. Lymphovascular Invasion and Lobular Histology are Associated with Increased Incidence of Isolated Tumor Cells in Sentinel Lymph Nodes from Early-Stage Breast Cancer Patients

   • Elizabeth A. Mittendorf
   • Aysegul A. Sahin
   • Kelly K. Hunt

   Breast Oncology 25 September 2008 Pages: 3369 - 3377

   

9. Sentinel Lymph Node Biopsy After Preoperative Chemotherapy for Breast Cancer: Findings from the Austrian Sentinel Node Study Group

   • Christoph Tausch
   • Peter Konstantiniuk
   • for the Austrian Sentinel Node Study Group

   OriginalPaper 06 July 2008 Pages: 3378 - 3383

10. Matched Pair Analyses of Stage IV Breast Cancer with or Without Resection of Primary Breast Site

    • B. Cady
    • N. R. Nathan
    • B. L. Smith

    Breast Oncology 23 August 2008 Pages: 3384 - 3395

    

11. Nipple-Sparing Mastectomy: Critical Assessment of 51 Procedures and Implications for Selection Criteria

    • Anna M. Voltura
    • Theodore N. Tsangaris
    • Charles M. Balch

    Breast Oncology 16 October 2008 Pages: 3396 - 3401

12. Feasibility of Sentinel Lymph Node Biopsy Through an Inframammary Incision for a Nipple-Sparing Mastectomy

    • John V. Kiluk
    • Alfredo A. Santillan
    • Charles E. Cox

    Breast Oncology 27 September 2008 Pages: 3402 - 3406

    

13. A Novel Assay to Assess the Effectiveness of Antiangiogenic Drugs in Human Breast Cancer

    • John M. Lyons III
    • Cathy T. Anthony
    • Eugene A. Woltering

    Breast Oncology 16 September 2008 Pages: 3407 - 3414

    

14. Contralateral Risk-Reducing Mastectomy in Young Breast Cancer Patients with and without Genetic Cancer Risk Assessment

    • Phuong L. Mai
    • Veronica I. Lagos
    • Jeffrey N. Weitzel

    Breast Oncology 04 October 2008 Pages: 3415 - 3421

15. Peritoneal Surface Disease from Colorectal Cancer: Comparison with the Hepatic Metastases Surgical Paradigm in Optimally Resected Patients

    • Perry Shen
    • Kurt Thai
    • Edward A. Levine

    Other 11 September 2008 Pages: 3422 - 3432

    

16. Preoperative Serum Carcinoembryonic Antigen Level as a Predictive Factor of Recurrence After Curative Resection of Colorectal Cancer

    • Ryo Takagawa
    • Syoichi Fujii
    • Hiroshi Shimada

    Gastrointestinal Oncology 10 October 2008 Pages: 3433 - 3439

    

17. Chemotherapy Has Also an Effect on Primary Tumor in Colon Carcinoma

    • M. Karoui
    • W. Koubaa
    • J. Tran Van Nhieu

    Gastrointestinal Oncology 11 October 2008 Pages: 3440 - 3446

    

18. Improving the Accuracy of TNM Staging in Esophageal Cancer: A Pathological Review of Resected Specimens

    • Sarah K. Thompson
    • Andrew R. Ruszkiewicz
    • Peter G. Devitt

    Gastrointestinal Oncology 01 October 2008 Pages: 3447 - 3458

    

19. Analysis of Gene Expression Identifies Differentially Expressed Genes and Pathways Associated with Lymphatic Dissemination in Patients with Adenocarcinoma of the Esophagus

    • S. M. Lagarde
    • P. E. Ver Loren van Themaat
    • J. J. B. van Lanschot

    Gastrointestinal Oncology 30 September 2008 Pages: 3459 - 3470

    

20. A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy

    • D. Beddy
    • J. M. P. Hyland
    • K. Sheahan

    Gastrointestinal Oncology 10 October 2008 Pages: 3471 - 3477

    

21. Different Patterns of Lymphatic Spread of Sigmoid, Rectosigmoid, and Rectal Cancers

    • In Ja Park
    • Gyu-Seog Choi
    • Soo Han Jun

    Gastrointestinal Oncology 01 October 2008 Pages: 3478 - 3483

22. Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma: A Retrospective Study

    • Hui-Hong Liang
    • Min-Shan Chen
    • Wan Yee Lau

    Hepatic and Pancreatic Tumors 05 August 2008 Pages: 3484 - 3493

    

23. Predictive Value of Expression and Promoter Hypermethylation of XAF1 in Hepatitis B Virus-Associated Hepatocellular Carcinoma Treated with Transplantation

    • Feng Zhang
    • Li-Ming Wu
    • Shu-Sen Zheng

    Laboratory and Translational Research 02 October 2008 Pages: 3494 - 3502

    

24. Tumour Size and Differentiation in Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation: External Validation of a New Prognostic Score

    • L. Marelli
    • A. Grasso
    • A. K. Burroughs

    Hepatic and Pancreatic Tumors 06 September 2008 Pages: 3503 - 3511

    

25. Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma

    • Shishir K. Maithel
    • Stephen Maloney
    • Peter J. Allen

    Hepatic and Pancreatic Tumors 10 September 2008 Pages: 3512 - 3520

    

26. Phase I/II Trial of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy and Surgery for Locoregionally Advanced Pancreatic Cancer

    • Jennifer L. Marti
    • Howard S. Hochster
    • Elliot Newman

    Hepatobiliary and Pancreatic Tumors 02 October 2008 Pages: 3521 - 3531

    

27. Surgical Approach and Perioperative Complications Determine Short-Term Outcomes in Patients with Insulinoma: Results of a Bi-Institutional Study

    • Christina L. Roland
    • Chung-Yau Lo
    • Fiemu E. Nwariaku

    Endocrine Tumors 30 September 2008 Pages: 3532 - 3537

    

28. Evaluation of the Sentinel Immunized Node for Immune Monitoring of Cancer Vaccines

    • Craig L. Slingluff Jr
    • Galina V. Yamshchikov
    • Jayashree Parekh

    Melanomas 16 October 2008 Pages: 3538 - 3549

    

29. Why Do Patients with Low-Grade Soft Tissue Sarcoma Die?

    • Robert J. Canter
    • Li-Xuan Qin
    • Murray F. Brennan

    Bone and Soft Tissue Sarcomas 01 October 2008 Pages: 3550 - 3560

    

30. Results After Conservative Treatment of Serous Borderline Tumors of the Ovary with a Micropapillary Pattern

    • Isabelle Laurent
    • Catherine Uzan
    • Philippe Morice

    Gynecologic Oncology 27 September 2008 Pages: 3561 - 3566

31. Venous Thromboembolism in Cancer Patients Undergoing Major Surgery

    • Nicolas H. Osborne
    • Thomas W. Wakefield
    • Peter K. Henke

    Other 08 October 2008 Pages: 3567 - 3578

    

32. Disturbed XIAP and XAF1 Expression Balance Is an Independent Prognostic Factor in Gastric Adenocarcinomas

    • Tomotaka Shibata
    • Tsuyoshi Noguchi
    • Katsunobu Kawahara

    Gastrointestinal Oncology 19 September 2008 Pages: 3579 - 3587

    

33. The Penetratin Sequence in the Anticancer PNC-28 Peptide Causes Tumor Cell Necrosis Rather Than Apoptosis of Human Pancreatic Cancer Cells

    • Wilbur B. Bowne
    • Kelley A. Sookraj
    • Matthew R. Pincus

    Laboratory and Translational Research 18 October 2008 Pages: 3588 - 3600

    

34. Expression and Secretion of Endostatin in Thyroid Cancer

    • Sebastian Hoffmann
    • Annette Wunderlich
    • Andreas Zielke

    Laboratory and Translational Research 26 September 2008 Pages: 3601 - 3608

    

35. Inflammatory Breast Cancer After Neoadjuvant Chemotherapy: Can Magnetic Resonance Imaging Precisely Diagnose the Final Pathological Response?

    • J.-H. Chen
    • R. S. Mehta
    • M.-Y. Su

    Breast Oncology 19 September 2008 Pages: 3609 - 3613

    

36. HER2 and Trastuzumab: Impact of a New Standard Agent on Local Control and Surgery for Breast Cancer

    • Dimosthenis Ziogas
    • Eleftheria Ignatiadou
    • Efstathios Lykoudis

    Breast Oncology 03 June 2008 Pages: 3614 - 3615

37. Surgical Decision-Making and the Influence of Biologic Markers: Reply

    • Swati Kulkarni
    • David Hicks

    Breast Oncology 23 September 2008 Pages: 3616 - 3616

38. Screening for or Prevention of Local Ipsilateral Recurrence and Contralateral Breast Cancer After Breast-Conserving Surgery?

    • Eleftheria Ignatiadou
    • Dimosthenis Ziogas
    • Theodore Liakakos

    Breast Oncology 10 July 2008 Pages: 3617 - 3619

39. Early Signet Ring Cell or Diffuse-Type Gastric Cancer: Risks for Endoscopic Mucosal Resection

    • Theodore Liakakos

    Gastrointestinal Oncology 01 February 2008 Pages: 3620 - 3621

40. Early Signet Ring Cell Gastric Cancer: Benefit for Endoscopic Mucosal Resection

    • Tae Kyung Ha

    Gastrointestinal Oncology 07 October 2008 Pages: 3622 - 3622

41. Increased Tissue Diffusion of Oxaliplatin During Laparoscopically Assisted Versus Open Heated Intraoperative Intraperitoneal Chemotherapy (HIPEC)

    • Fabienne Thomas
    • Gwenaël Ferron
    • Etienne Chatelut

    Gynecologic Oncology 26 August 2008 Pages: 3623 - 3624

    

42. The Keystone Island and Pedicle Flap: a Handy Local Flap for Soft Tissue Reconstruction

    • Christo D. Shipkov
    • Ali Mojallal

    Melanomas 26 August 2008 Pages: 3625 - 3625